ArticleEuropean heart journal2023
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Erratum issued 15 registry-linked trialsAbstract read
In one paragraph
Article in European heart journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It reports registered trial NCT07022379. Cited by 1,294 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,294citing papers in PubMed, 5 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT07022379 completed
Temporal Trends and Determinants of Sodium-Glucose Cotransporter 2 Inhibitor Use in Patients Enrolled in a Nationwide Heart Failure Remote Monitoring Program
Open the trial in the graphNaples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)
The Role and Mechanism of Gut Microbiota and Metabolites in Heart Failure With Preserved Ejection Fraction
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial (STEPS Trial)
Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis - A Multicentre Prospective Cohort Study
Development and Implementation of a National Multicenter Registry for Pediatric End-Stage Heart Failure in China
Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME
FASTTRACK - Facilitated Access to Optimized Treatment and Clinical Follow-Up for Elderly Patients by the Internal Medicine Heart Failure Outpatient Clinic - a Randomized Multicenter Prospective Study
Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Reduced Ejection Fraction: Randomized Controlled Feasibility Trial
The Role of a Structured Patient Education Programme in the Complex Care of Patients With Heart Failure
Anemia Therapy in Patients With Infective Endocarditis (POET-IRON)
OBESE-HFpEF: Prevalence and Mediators of Heart Failure (Preserved Ejection Fraction) in the Dutch Obesity Clinic South - Towards Preventing Obesity Related HFpEF''
Evaluation of a Treatment Algorithm for the Management of TAVI Patients With Significant Concomitant Mitral or Tricuspid Regurgitation
Phenotyping Heart Failure With Preserved Ejection Fraction (HFpEF) Using Echocardiographic, Clinical, and Biomarker Parameters
Who cites it
1,294 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Metallomic Dysregulation and Cardiovascular Disease: Essential Trace Elements, Non-essential Metal Exposure, and Heart Failure Risk: A Systematic Review.Cardiovascular toxicology · 2026Pooled it
- Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations.European heart journal. Quality of care & clinical outcomes · 2026Pooled it
- Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters-an updated meta-analysis.ESC heart failure · 2026Pooled it
- 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Journal of the American College of Cardiology · 2026Guideline
- Cardiovascular, limb, and kidney effects of SGLT2 inhibitors in patients with peripheral artery disease: a systematic review and meta-analysis of randomized controlled trial data.Cardiovascular diabetology · 2026Pooled it
- Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics and the Pharmacokinetics of Balcinrenone When Dosed with a P-gp Inhibitor.Journal of clinical pharmacology · 2026Trial
- Early palliative care in heart failure shows neutral effects across EF subtypes: an exploratory EPCHF secondary analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Trial
- Trial
- Trial
- Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry.ESC heart failure · 2026Trial
- Evaluating the prognostic value of admission IL-8 and sST2 as biomarkers of early myocardial injury in severe community-acquired pneumonia.Annals of medicine · 2026Article
- Exercise, Nutrition and GLP-1 Medicines to Improve Body Weight and Muscle Function in Heart Failure with Preserved Ejection Fraction.Current heart failure reports · 2026Review
- Precision Use of Ivabradine in Contemporary HFrEF: From Heart Rate Reduction to Physiological Optimization.Cardiovascular drugs and therapy · 2026Review
- Cost-effectiveness of early empagliflozin initiation after acute myocardial infarction: a German statutory health insurance perspective.Cost effectiveness and resource allocation : C/E · 2026Article
- Eosinophilia and the Heart: Evolving Concepts.Current cardiology reports · 2026Review
- From snapshot to trajectory: A multimodality right-heart monitoring framework across the heart failure spectrum.American heart journal plus : cardiology research and practice · 2026Review
- The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.British journal of clinical pharmacology · 2026Article
- Predicting left-ventricular recovery and characterizing Cardiorenal risk after Transcatheter aortic valve replacement: A routine-data phenotyping and prediction-model study.International journal of cardiology. Heart & vasculature · 2026Article
- SGLT2 inhibitor prescription at discharge in very old adults with heart failure irrespective of diabetes status.International journal of cardiology. Heart & vasculature · 2026Article
- Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy.Advances in therapy · 2026Article
1,234 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
31 authors.
Theresa A McDonagh(Chairperson) (United Kingdom).ORCID 0000-0003-1305-9602
Marco Metra(Chairperson) (Italy).ORCID 0000-0001-6691-8568
Marianna Adamo(Task Force Co-ordinator) (Italy).ORCID 0000-0002-3855-1815
Roy S Gardner(Task Force Co-ordinator) (United Kingdom).ORCID 0000-0002-6792-6671
Andreas Baumbach(United Kingdom).ORCID 0000-0001-7707-2254
Michael Böhm(Germany).ORCID 0000-0002-2976-2514
Haran Burri(Switzerland).ORCID 0000-0002-4393-5338
Javed Butler(United States of America).ORCID 0000-0001-7683-4720
Jelena Čelutkienė(Lithuania).ORCID 0000-0003-3562-9274
Ovidiu Chioncel(Romania).ORCID 0000-0002-3197-3628
John G F Cleland(United Kingdom).ORCID 0000-0002-1471-7016
Maria Generosa Crespo-Leiro(Spain).ORCID 0000-0002-3085-167X
Dimitrios Farmakis(Greece).ORCID 0000-0001-8364-3447
Martine Gilard(France).ORCID 0000-0002-2794-7953
Stephane Heymans(Netherlands).ORCID 0000-0001-9477-7803
Arno W Hoes(Netherlands).ORCID 0000-0002-8747-6479
Tiny Jaarsma(Sweden).ORCID 0000-0002-4197-4026
Ewa A Jankowska(Poland).ORCID 0000-0002-9202-432X
Mitja Lainscak(Slovenia).ORCID 0000-0002-5922-4098
Carolyn S P Lam(Singapore).ORCID 0000-0003-1903-0018
Alexander R Lyon(United Kingdom).ORCID 0000-0001-8026-840X
John J V McMurray(United Kingdom).ORCID 0000-0002-6317-3975
Alexandre Mebazaa(France).ORCID 0000-0001-8715-7753
Richard Mindham(United Kingdom).ORCID 0000-0003-1116-5284
Claudio Muneretto(Italy).ORCID 0000-0003-2656-4544
Massimo Francesco Piepoli(Italy).ORCID 0000-0003-1124-234X
Susanna Price(United Kingdom).ORCID 0000-0002-6425-3360
Giuseppe M C Rosano(United Kingdom).
Frank Ruschitzka(Switzerland).ORCID 0000-0001-5972-0596
Anne Kathrine Skibelund(Denmark).
ESC Scientific Document Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Heart FailureHumansStroke VolumeAcute heart failureChronic kidney disease hospitalizationComorbiditiesDiagnosisEjection fractionGuidelinesHeart failureMultidisciplinary managementNatriuretic peptidesNeurohormonal antagonistsPharmacotherapyPrevention
Identifiers
PMID
37622666What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT07022379ClinicalTrials.gov
NCT06162247ClinicalTrials.gov
NCT06645535ClinicalTrials.gov
NCT06667128ClinicalTrials.gov
NCT06668389ClinicalTrials.gov
NCT06838507ClinicalTrials.gov
and 9 more above
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.